| Hazard Information | Back Directory | [Description]
JN403 is a selective nicotinic acetylcholine receptor alpha7 agonist. | [Uses]
JN403 is an orally active and selective α7 nicotinic acetylcholine receptor agonist. JN403 can be used in the study of central nervous system disorders[1]. | [References]
[1] Feuerbach D, et al. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain. Neuropharmacology. 2009 Jan;56(1):254-63. |
|
|